Filter
1593
Text search:
drug
registration
Featured
126
535
Language
Document type
1076
194
156
65
60
14
13
9
5
1
Countries / Regions
162
58
47
43
37
37
36
36
36
35
35
34
34
32
31
29
25
23
23
21
21
19
17
17
17
16
14
13
12
10
9
9
8
7
6
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
824
121
78
42
32
23
16
1
Toolboxes
176
149
75
72
71
40
36
29
25
25
23
17
16
15
13
7
7
6
5
5
2
2
2
World Drug Report 2018
-3-
2nd edition
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of
...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
Revised National Tuberculosis Control Programme
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass
...
